Divisadero Street Capital Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-38,015
Closed -$28.9K 107
2024
Q3
$28.9K Sell
38,015
-13,593
-26% -$17.8K ﹤0.01% 74
2024
Q2
$92.9K Sell
51,608
-1,487,839
-97% -$4.29M 0.01% 61
2024
Q1
$7.33M Buy
+1,539,447
New +$5.41M 1.72% 15
2023
Q3
Sell
-38,385
Closed -$82.5K 62
2023
Q2
$82.5K Sell
38,385
-186,901
-83% -$453K 0.02% 42
2023
Q1
$656K Sell
225,286
-408,852
-64% -$2.06M 0.29% 40
2022
Q4
$4.36M Buy
634,138
+439,294
+225% +$2.07M 3.26% 12
2022
Q3
$620K Buy
+194,844
New +$708K 0.69% 35

Other funds holding STIM

Divisadero Street Capital Management's STIM Position: Q4 2024 in Review

Divisadero Street Capital Management sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 38,015 shares — an estimated $28.9K sold.

Divisadero Street Capital Management first reported a position in STIM in Q3 2022 and held it in 7 quarters. The position peaked at $7.33M in Q1 2024. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

  • Divisadero Street Capital Management reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
  • Divisadero Street Capital Management sold 38,015 Neuronetics shares in Q4 2024, an estimated $28.9K.
  • Divisadero Street Capital Management first reported a position in Neuronetics in Q3 2022 and held it in 7 quarters.
  • Divisadero Street Capital Management's Neuronetics position peaked at $7.33M in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on Divisadero Street Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.